Cargando…
Direct renin inhibition – a promising strategy for renal protection?
Activation of the renin–angiotensin–aldosterone system (RAAS) plays a key role in the progression of chronic kidney disease (CKD). RAAS inhibitors, such as angiotensin converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs), decrease the rate of progression of diabetic and n...
Autores principales: | Lizakowski, Sławomir, Tylicki, Leszek, Rutkowski, Bolesław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684114/ https://www.ncbi.nlm.nih.gov/pubmed/23756824 http://dx.doi.org/10.12659/MSM.883949 |
Ejemplares similares
-
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial
por: Lizakowski, Sławomir, et al.
Publicado: (2012) -
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system
por: Viazzi, Francesca, et al.
Publicado: (2013) -
Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007) -
New class of agents for treatment of hypertension: focus on direct renin inhibition
por: Fogari, Roberto, et al.
Publicado: (2010) -
No effects of ozonated autohemotherapy on inflammation response in hemodialyzed patients.
por: Tylicki, Leszek, et al.
Publicado: (2004)